Page 3 - Oxford University

Easy to store and cheaper, Oxford's Covid shot may be vaccine for the world

Astra vaccine accounts for more than 40% of supplies going to low- and middle-income nations

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Sources close to the development said the expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine

UK becomes world's first nation to approve AstraZeneca-Oxford Covid vaccine

The government has today accepted the recommendation to authorise Oxford University/AstraZeneca's Covid-19 vaccine for use, the health ministry said

Nod for Covid vaccine in the next few days: Serum Institute's Poonawalla

SII has stockpiled 40-50 mn doses and is adding more every week. Most of these will come to India, as exporting would require fulfilling WHO's pre-qualification procedures

Oxford/AstraZeneca vaccine should be effective against new variant: Report

The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, the report said

Oxford Covid vaccine may be first to get govt nod for emergency use: Report

The process of granting emergency use approval for Bharat Biotech''s COVID-19 vaccine ''Covaxin'' may take time as its phase 3 trials are still underway, while Pfizer is yet to make a presentation

India likely to approve AstraZeneca vaccine by next week: Sources

This could be the first country to give the regulatory green light for the British drugmaker's vaccine as the British medicine regulator continues to examine data from the trials

Serum Institute to seek nod for two full-dose regimen of Covishield

Suresh Jadhav, executive director of the Pune-based firm, said on Friday Serum was seeking approval from the Drug Controller General of India (DCGI) for the two-full dose regimen

AstraZeneca's Covid-19 vaccine 70.4% effective at preventing the infection

AstraZeneca's Covid-19 vaccine is safe and effective at preventing symptomatic infection and it protects against severe disease and hospitalisation, a study concluded

Serum seeks emergency use nod for Oxford's Covid-19 vaccine in India

According to the ICMR, the SII has already manufactured 40 million doses of the vaccine under the at-risk manufacturing and stockpiling license it obtained from the DCGI

Fortune or foresight? AstraZeneca, Oxford stories clash on Covid-19 vaccine

The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose

Volunteer for Oxford's Covid-19 vaccine seeks Rs 5 crore compensation

Vaccine 'Covishield' is being manufactured by Pune-based Serum Institute of India

India Coronavirus Dispatch: Situation remains grim in national capital

Covid may impact vision of some patients, ethical dilemma of denying vaccine to trial participants, UP artisans start selling online-news relevant to India's fight against the pandemic

AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: SII

Serum Institute of India said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly

Thailand to sign Covid-19 vaccine agreement with Oxford-AstraZeneca

The announcement comes as other countries in the region like the Philippines prepare to sign similar deals with AstraZeneca

AstraZeneca faces more Covid-19 vaccine questions after manufacturing error

Oxford said a difference in manufacturing processes led to later phases of the trials having a half-dose given instead of a full one

How a dosing error turned into lucky punch for AstraZeneca and Oxford

"The reason we had the half-dose is serendipity," Mene Pangalos, the head of AstraZeneca's non-oncology research and development, told Reuters

Oxford-AstraZeneca vaccine shows positive results, up to 90% efficacy

Data from global trials to be submitted to the Indian regulator by the end of December

Serum Institute to focus on supplying Oxford Covid vaccine to India first

Poonawalla said the company will be able to produce 400 million doses of AstraZeneca's vaccine by July 2021 and scale up further from there

Covid-19 crisis: Oxford scientists expect vaccine data by Christmas

Pollard said there is no competition between the various research teams, because several vaccines will be needed to bring the global pandemic under control and allow life to return to normal